Post Partum Haemorrhage Clinical Trial
Official title:
Use of Quantra® System in Clinical Practice to Improve Management of Post-partum Haemorrhage : a Prospective Study
Post partum haemorrhage is a concerning situation in maternity wards, though it is not the first cause of maternal mortality anymore. It has been already shown that low fibrinogen level is a major predictive factor of massive bleeding after delivery. In this situation, the early knowledge of fibrinogen level could enhance care of women experiencing post partum haemorrhage. In a cohort of women suffering from post partum haemorrhage, this study will evaluate whether assessing fibrinogen level would be faster using the Quantra® system than the standard coagulation test.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02303418 -
Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Undergoing Caesarean Sections for Placenta Previa: A Randomised Controlled Trial
|
Phase 3 | |
| Recruiting |
NCT00344929 -
Severe Post Partum Haemorrhage (PPH): A Randomized Trial on Transversal Intervention in 6 French Perinatal Networks
|
N/A | |
| Completed |
NCT02775773 -
Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH
|
Phase 3 | |
| Completed |
NCT02216383 -
Intramuscular Oxytocics: A Randomised Control Trial
|
Phase 3 | |
| Completed |
NCT01571323 -
Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean Section
|
Phase 1/Phase 2 | |
| Terminated |
NCT02908126 -
Compare Efficacy of Oxytocin Administrations on Postpartum Uterine Contractility
|
Phase 1 | |
| Terminated |
NCT02900690 -
Health Economics Evaluation of the Management of Severe Postpartum Hemorrhage: Comparison of Recombinant Activated Factor VII Strategy to the Reference Strategy
|